US Broker Ratings

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Unveiling a 121.77% Potential Upside in Biotech Innovation

CytomX Therapeutics, Inc. (NASDAQ: CTMX), a trailblazer in the biotechnology sector, is catching the eye of investors with its promising innovations in oncology-focused biologics. Headquartered in..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Biotech Potential with a 17.5% Upside

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) presents a compelling opportunity for investors seeking exposure to the biotechnology sector. With a market capitalization of $374.08 million, this clinical-stage..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A 394.87% Potential Upside Awaits Investors

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a cutting-edge biotechnology company specializing in mRNA-based therapeutics, presents a compelling investment opportunity with a staggering potential upside of nearly..

Shopify Inc. (SHOP) Stock Analysis: Balancing Growth and Valuation with a 16% Return on Equity

Investors with an eye on the technology sector are likely familiar with Shopify Inc. (NYSE: SHOP), a Canadian-based commerce technology powerhouse. The company, which has a..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 239.50% Potential Upside in Gene Therapy

Investors seeking opportunities in the rapidly evolving biotechnology sector might want to keep a keen eye on Abeona Therapeutics Inc. (ABEO). As a clinical-stage biopharmaceutical company,..

Tvardi Therapeutics, Inc. (TVRD) Investor Outlook: Exploring a 162% Potential Upside in the Biotech Arena

Tvardi Therapeutics, Inc. (NASDAQ: TVRD), a burgeoning biotechnology company based in Sugar Land, Texas, is attracting significant attention from investors due to its innovative approach to..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Navigating a 10.27% Potential Upside Amidst Mixed Signals

ZoomInfo Technologies Inc. (NASDAQ: GTM), a prominent player in the technology sector, offers a robust platform that provides go-to-market intelligence and engagement solutions for professionals across..

Sprout Social, Inc (SPT) Stock Analysis: Navigating a 29% Potential Upside in the Social Media Software Sector

Sprout Social, Inc (NASDAQ: SPT), a key player in the technology sector specializing in application software, is capturing investor attention with a notable 29.25% potential upside,..

A2Z Cust2Mate Solutions Corp. (AZ) Stock Analysis: Exploring a 102.84% Potential Upside

Investors seeking opportunities in the technology sector may want to pay close attention to A2Z Cust2Mate Solutions Corp. (AZ), a Canadian firm making waves with its..

Asure Software Inc. (ASUR) Stock Analysis: Capitalizing on a 33% Potential Upside

Asure Software Inc. (NASDAQ: ASUR), a key player in the cloud-based Human Capital Management (HCM) industry, is garnering significant attention from investors due to its compelling..

Nyxoah SA (NYXH) Stock Analysis: Unveiling a 74.52% Potential Upside in the Sleep Apnea Market

Nyxoah SA (NASDAQ: NYXH), a Belgian-based innovator in the healthcare sector, is making waves in the medical instruments industry with its groundbreaking approach to treating obstructive..

Quhuo Limited (QH): A Closer Look at the Gig Economy Innovator’s Stock Performance and Growth Potential

Quhuo Limited, trading under the symbol QH, is a notable player in the technology sector, specifically within the software application industry. Based in China, the company..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Unveiling a Potential 64% Upside in the Healthcare Sector

Nano-X Imaging Ltd (NASDAQ: NNOX), a pioneer in the medical devices industry, is garnering attention with its cutting-edge digital X-ray technology and enticing growth potential. With..

Canopy Growth Corporation (CGC): Investor Outlook Highlighting a Potential 95% Upside

Canopy Growth Corporation (NASDAQ: CGC), a key player in the cannabis sector, has captured investor attention with its potential upside of 95.30%. As the company navigates..

Phathom Pharmaceuticals (PHAT): Investor Outlook Highlights a Promising 123% Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is making waves in the healthcare sector with its innovative approach to treating gastrointestinal diseases. As a biotechnology company, Phathom is..

SoundHound AI, Inc. (SOUN) Stock Analysis: Unpacking the 151% Revenue Growth and Market Potential

SoundHound AI, Inc. (NASDAQ: SOUN) has been catching the eyes of investors with its striking 151.20% revenue growth in the technology sector, particularly within the software..

Aura Biosciences, Inc. (AURA) Stock Analysis: A 232% Upside Potential in a Promising Biotechnology Sector

Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology firm, is garnering significant attention from investors, and for good reason. With an impressive potential upside of 232.82%..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Exploring an 80.92% Potential Upside in the Biotechnology Sector

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is making waves in the biotechnology sector with a market capitalization of $333.32 million. Known for its innovative approach in treating..

Exxon Mobil (XOM) Investor Outlook: Exploring an 11.72% Upside Potential

Exxon Mobil Corporation (NYSE: XOM), a stalwart in the energy sector, continues to command attention with its substantial market cap of $478.59 billion. As an integrated..

Pacific Biosciences of California (PACB) Stock Analysis: Unveiling a 37.92% Potential Upside in the Healthcare Sector

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a key player in the healthcare sector specializing in medical devices, has become a focal point for investors eyeing..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds